FREEM: Record sales, fusion breakthroughs, and China entry drive growth in AM and medtech

About this update from Freemelt Holding Ab

A differentiated, modular approach in additive manufacturing is driving growth across defense, energy, and medtech, with record sales and strategic expansion into China. Fusion energy projects highlight the value of AM tungsten components, while medtech adoption and financial stability support a positive outlook.Based on This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Freemelt Holding Ab